Stay Updated

Matrixyl

Also known as: Palmitoyl Pentapeptide-4, Pal-KTTKS, Palmitoyl pentapeptide, Palmitoyl-Lys-Thr-Thr-Lys-Ser, historical name Palmitoyl Pentapeptide-3, Original Matrixyl

3 notable studies · 3 references

View Supplier Listings Take This Matrixyl Study With You

TLDR

Matrixyl is a trade name best known for the original cosmetic peptide Palmitoyl Pentapeptide-4 (Pal-KTTKS), a palmitoylated collagen-derived signaling peptide with controlled human topical evidence showing modest improvement in fine lines and wrinkles, but the Matrixyl name now covers multiple peptide formulations and the existing evidence does not establish systemic or injectable regenerative effects.

Research Supports

  • Studied in controlled topical human trials for fine lines and wrinkles
  • Investigated for stimulating fibroblast production of extracellular-matrix components
  • Studied for topical delivery and formulation effects on skin penetration
  • Examined in experimental wound-healing and tissue-repair models

Observations Reported in Research

  • Robinson et al., 2005 (n=93): 3 ppm Pal-KTTKS showed significantly greater fine-line/wrinkle improvement than vehicle at 12 weeks
  • 2023 trial (n=21): Palmitoyl Pentapeptide-4 produced favorable changes in crow's-feet appearance over 8 weeks
  • Laboratory research links KTTKS/Pal-KTTKS to type-I/III collagen, fibronectin, and elastin-related matrix production
  • No controlled evidence establishes injectable or systemic efficacy for Matrixyl

These are brief summaries of what the referenced research examined or reported — not conclusions about safety or effectiveness, and not medical advice. See Notable Studies and Sources & References below for the full context and citations.

At a Glance

Classification: Synthetic palmitoylated pentapeptide; lipopeptide; matrikine-derived cosmetic signal peptide

Matrixyl is the trade name most closely associated with Palmitoyl Pentapeptide-4 (Pal-KTTKS), a five-amino-acid collagen-derived signaling sequence attached to a palmitic-acid lipid chain. The peptide portion is Lys-Thr-Thr-Lys-Ser — KTTKS and the complete molecule is commonly written Pal-KTTKS. KTTKS is derived from type-I procollagen biology. Adding the palmitoyl group increases lipophilicity and was intended to make the peptide more useful for topical skin delivery. Matrixyl is primarily studied for fine lines and wrinkles, photoaged skin, collagen/extracellular-matrix signaling, fibroblast activity, skin texture, and cosmetic skin aging. Unlike many research-market peptides, Matrixyl has controlled human topical evidence. A 12-week double-blind, vehicle-controlled study involving 93 women found significantly greater improvement in fine lines and wrinkles with topical Pal-KTTKS than with the vehicle alone. But the name has an important catch: Matrixyl is a trade name, not an unambiguous chemical name. The original Matrixyl is associated with Palmitoyl Pentapeptide-4. Later members of the Matrixyl family use different peptides or peptide combinations. Therefore a study of original Matrixyl/Pal-KTTKS is not automatically evidence for every product labeled Matrixyl.

What Is Matrixyl?

Original Matrixyl is a palmitoylated pentapeptide. Its peptide sequence is KTTKS or Lys-Thr-Thr-Lys-Ser. Attaching palmitic acid creates Palmitoyl-Lys-Thr-Thr-Lys-Ser, which is Pal-KTTKS, Palmitoyl Pentapeptide-4, the ingredient historically marketed as Matrixyl. The peptide is often described as a matrikine—a small peptide associated with extracellular-matrix breakdown/remodeling that can function as a biological signal. Instead of supplying collagen directly, the research rationale is collagen-associated peptide signal, then fibroblast response, then extracellular-matrix production. The palmitic-acid portion primarily addresses delivery by making the otherwise hydrophilic peptide more lipophilic.

What Are Researchers Studying?

Fine lines and wrinkles

This is Matrixyl's strongest human research area. In the best-known controlled study, 93 women aged 35–55 used a moisturizer containing 3 ppm Pal-KTTKS on one side of the face and the same vehicle without the peptide on the other. After 12 weeks, quantitative image analysis and expert grading showed significantly greater improvement in fine lines and wrinkles on the Pal-KTTKS-treated side. This gives Matrixyl something many cosmetic peptides lack: direct controlled human evidence. But the observed effects were cosmetic and relatively modest—not dramatic skin regeneration.

Extracellular-matrix production

Laboratory research suggests KTTKS/Pal-KTTKS can influence fibroblast production of extracellular-matrix components. Reported targets include type-I collagen, type-III collagen, fibronectin, elastin-related matrix biology, and glycosaminoglycans. This forms the mechanistic basis for Matrixyl's classification as a signal peptide rather than simply an antioxidant or moisturizer.

Photoaged skin

Matrixyl has primarily been investigated as a topical cosmetic ingredient for age-associated skin changes. The clinical literature focuses on endpoints such as fine-line appearance, wrinkle appearance, skin roughness, and skin texture. That evidence should not be expanded into a claim that Matrixyl reverses biological aging. Improvement in the appearance of photoaged skin is not systemic anti-aging.

Skin delivery

KTTKS itself is relatively hydrophilic, creating a challenge for penetration through the lipid-rich stratum corneum. Palmitoylation increases lipophilicity and is intended to improve topical delivery. Contemporary research continues investigating formulation and delivery because getting a peptide into the relevant skin layers remains an important determinant of activity. Therefore Pal-KTTKS in one formulation doesn't necessarily produce identical exposure to Pal-KTTKS in another formulation. Vehicle, concentration and formulation matter.

Wound and tissue repair

Matrixyl has also appeared in experimental wound-healing research. These studies provide additional information about collagen and extracellular-matrix biology, but the evidence is substantially less mature than its cosmetic use. A wound-healing experiment should therefore not be converted into a claim that Matrixyl heals injuries in humans. Its best-supported application remains topical skin/cosmetic research.

How Does It Work?

The proposed pathway is roughly: Matrixyl / Pal-KTTKS, then interaction with skin/fibroblast signaling, then extracellular-matrix response, then increased synthesis of matrix components such as collagen, then gradual changes in skin structure, then modest improvement in visible fine lines/wrinkles. There is no well-established single Matrixyl receptor comparable with GLP-1 to GLP-1R or oxytocin to OXTR. Matrixyl is better described as an extracellular-matrix signaling peptide.

What Does the Research Show?

Human research

MODERATE. There is genuine controlled human evidence supporting modest improvement in visible photoaging/fine lines with specific Pal-KTTKS formulations. However: the literature is relatively small; much of it is commercially connected; specific formulations have been studied; cosmetic endpoints dominate; large independent pharmaceutical-style trials don't exist. Injectable/systemic use is NOT ESTABLISHED. Human topical Matrixyl evidence does not establish injectable Matrixyl efficacy, systemic collagen regeneration, tendon repair, ligament repair, muscle recovery, joint regeneration, or whole-body anti-aging.

Animal research

LIMITED–MODERATE. Animal and experimental models have investigated wound healing and extracellular-matrix effects, but this isn't the foundation of Matrixyl's strongest evidence.

In-vitro research

MODERATE. Cellular research supports effects involving fibroblasts and extracellular-matrix production and provides the primary mechanistic rationale for its cosmetic use.

Notable Studies

Topical Palmitoyl Pentapeptide Provides Improvement in Photoaged Human Facial Skin

human

Robinson LR, Fitzgerald NC, Doughty DG, Dawes NC, Berge CA, Bissett DL · 2005

Ninety-three women aged 35–55 used a topical moisturizer containing 3 ppm Pal-KTTKS and the corresponding vehicle control for 12 weeks. Quantitative image analysis and expert grading showed significantly greater improvement in fine lines/wrinkles with Pal-KTTKS.

Limitations: The study evaluated a specific topical cosmetic formulation rather than Matrixyl in every possible formulation. Outcomes were cosmetic rather than disease endpoints, and investigators included researchers affiliated with Procter & Gamble.

View publication →

Double-Blind, Randomized Trial on the Effectiveness of Acetylhexapeptide-3 Cream and Palmitoyl Pentapeptide-4 Cream for Crow's Feet

human

2023

Twenty-one women were assigned to topical Palmitoyl Pentapeptide-4, acetylhexapeptide-3 or placebo treatment for eight weeks. Palmitoyl Pentapeptide-4 produced favorable changes across several measurements of crow's-feet appearance.

Limitations: Only 21 participants were included, making this a very small trial. Treatment duration was short and outcomes were cosmetic.

View publication →

Matrixyl Patch vs Matrixyl Cream: A Comparative In Vivo Investigation of Matrixyl (MTI) Effect on Wound Healing

animal

Kachooeian M, Mousivand Z, Sharifikolouei E, et al. · 2022

Researchers compared Matrixyl delivered through different topical systems and examined wound-healing and collagen-related outcomes. The experiment provides supporting evidence that formulation and delivery can influence biological effects.

Limitations: Preclinical rather than human evidence. It does not establish Matrixyl as a human wound-healing treatment.

View publication →

What We Still Don't Know

Optimal topical concentration. Which delivery systems work best. How much intact Pal-KTTKS reaches viable dermal tissue. Long-term effects of continuous use. Durability after discontinuation. Comparative effectiveness against retinoids and other established approaches. Whether newer Matrixyl-family formulations outperform original Matrixyl. Whether results from one formulation generalize to another. Systemic pharmacokinetics. Systemic efficacy. Injectable safety. Injectable efficacy. Whether matrix-signaling effects translate meaningfully to tissues outside skin.

Related Compounds

GHK-CU

Take the Matrixyl research with you.

Get the Aminodex Matrixyl Brief—a concise summary of the research, notable studies, evidence types, limitations, and references.

One-time email. We do not add you to any mailing list.

Sources & References

  1. Robinson LR, Fitzgerald NC, Doughty DG, Dawes NC, Berge CA, Bissett DL. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. International Journal of Cosmetic Science. 2005;27(3):155–160.
  2. Controlled human study of Palmitoyl Pentapeptide-4 versus acetylhexapeptide-3 and placebo for crow's feet.
  3. Kachooeian M, et al. Matrixyl patch vs Matrixyl cream: comparative in vivo investigation of Matrixyl effect on wound healing.

Supplier Listings

A directory of relevant research suppliers for this compound is not yet available.